Publication | Open Access
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
46
Citations
47
References
2021
Year
Our data demonstrate that tumor DNA methylation profiles may serve as a predictive marker for response to anti-PD-1 ICI therapy in sarcoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1